Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
4.920
-0.180 (-3.53%)
May 6, 2025, 12:13 PM EDT - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
T Cell Redirecting Immunotherapies
58.38M
Log In
Log In
Log In
Log In
Upgrade
T Cell Redirecting Immunotherapies Growth
-67.86%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Germany
58.38M
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
-67.86%
Log In
Log In
Log In
Log In
Upgrade